(Adds product sales, background on scrapped Shire deal). Oct 31 (Reuters) - AbbVie, which this month walked away from a $55 billion deal to buy Dublin drugmaker Shire , on Friday reported quarterly revenue and earnings well above Wall Street ...
AbbVie raises outlook as profit, sales beat
AbbVie (ABBV) Rising Before The Market Opens
Related articles »